TRAVERE THERAPEUTICS, INC. (TVTX) Return on equity 2016–2025
TRAVERE THERAPEUTICS, INC. (TVTX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-22.2%FY2025 · since FY2016: -15.6% → -22.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -22.2% | +522.0 pp |
| FY2024 | -544.3% | -488.8 pp |
| FY2023 | -55.5% | +594.4 pp |
| FY2022 | -649.9% | -590.3 pp |
| FY2021 | -59.6% | +20.6 pp |
| FY2020 | -80.2% | -14.0 pp |
| FY2019 | -66.2% | -33.9 pp |
| FY2018 | -32.3% | -11.9 pp |
| FY2017 | -20.4% | -4.8 pp |
| FY2016 | -15.6% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice